Four published articles using OD have reported slightly significant difference between patients who are immunocompromised and healthy group (SMD= −0.94 95%CI: −1.50 to −0.38) in Figure 7 .
← all excerpts
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.
1
—
—